InterCure Ltd.
(NASDAQ: INCR)

INC Research Holdings Inc (INC Research) is a contract research organization (CRO). The Company is engaged in Strategic clinical development, which provides a range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry; Standalone services, such as Project management, Data and biostatistics, Monitoring, Quality and compliance, Safety and pharmacovigilance, Regulatory affairs, Study start-up, Patient recruitment, Pregnancy registries, Abuse liability, Alcohol interactions and Medical writing, and Pharmaceutical consulting. The Company operates in North America, South America, Central Europe, Southern Europe, Western Europe, Middle East, Asia Pacific and Africa. The Company uses web-based electronic endpoint adjudication systems and monitoring techniques.

0.926 -

-0.004 (-0.43%)
Range 0.926 - 0.926   (-%)
Open 0.926
Previous Close 0.930
Bid Price 0.908
Bid Volume 100
Ask Price 0.952
Ask Volume 100
Volume 166
Value 114
Remark -
Delayed prices. Updated at 30 Jan 2026 00:51.
Data powered by
View All Events

About InterCure

INC Research Holdings Inc (INC Research) is a contract research organization (CRO). The Company is engaged in Strategic clinical development, which provides a range of Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industry; Standalone services, such as Project management, Data and biostatistics, Monitoring, Quality and compliance, Safety and pharmacovigilance, Regulatory affairs, Study start-up, Patient recruitment, Pregnancy registries, Abuse liability, Alcohol interactions and Medical writing, and Pharmaceutical consulting. The Company operates in North America, South America, Central Europe, Southern Europe, Western Europe, Middle East, Asia Pacific and Africa. The Company uses web-based electronic endpoint adjudication systems and monitoring techniques.

Loading Chart...

Please login to view stock data and analysis